Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1983 1
1984 1
1986 3
1987 6
1988 2
1989 2
1990 3
1991 5
1992 2
1993 3
1994 3
1995 1
1999 1
2001 1
2002 8
2004 2
2005 1
2006 2
2007 3
2008 4
2009 6
2010 3
2011 2
2012 2
2013 3
2014 3
2015 7
2016 4
2017 2
2018 1
2019 7
2020 7
2021 6
2022 4
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
The choice of first-line chronic myelogenous leukemia treatment.
Fava C, Rege-Cambrin G, Saglio G. Fava C, et al. Among authors: rege cambrin g. Ann Hematol. 2015 Apr;94 Suppl 2(Suppl 2):S123-31. doi: 10.1007/s00277-015-2321-3. Epub 2015 Mar 27. Ann Hematol. 2015. PMID: 25814078 Free PMC article. Review.
Update on emerging treatments for chronic myeloid leukemia.
Fava C, Morotti A, Dogliotti I, Saglio G, Rege-Cambrin G. Fava C, et al. Among authors: rege cambrin g. Expert Opin Emerg Drugs. 2015 Jun;20(2):183-96. doi: 10.1517/14728214.2015.1031217. Epub 2015 Mar 31. Expert Opin Emerg Drugs. 2015. PMID: 25826695 Review.
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.
Iurlo A, Cattaneo D, Consonni D, Castagnetti F, Miggiano MC, Binotto G, Bonifacio M, Rege-Cambrin G, Tiribelli M, Lunghi F, Gozzini A, Pregno P, Abruzzese E, Capodanno I, Bucelli C, Pizzuti M, Artuso S, Iezza M, Scalzulli E, La Barba G, Maggi A, Russo S, Elena C, Scortechini AR, Tafuri A, Latagliata R, Caocci G, Bocchia M, Galimberti S, Luciano L, Fava C, Foà R, Saglio G, Rosti G, Breccia M. Iurlo A, et al. Among authors: rege cambrin g. Front Pharmacol. 2023 Mar 23;14:1154377. doi: 10.3389/fphar.2023.1154377. eCollection 2023. Front Pharmacol. 2023. PMID: 37033642 Free PMC article.
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor.
Fava C, Rege-Cambrin G, Dogliotti I, Gottardi E, Berchialla P, Di Gioacchino B, Crasto F, Lorenzatti R, Volpengo A, Daraio F, Fantino C, Saglio G. Fava C, et al. Among authors: rege cambrin g. Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S96-S100. doi: 10.1016/j.clml.2016.03.008. Epub 2016 Apr 1. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27131622 Review.
Chronic myeloid leukemia: state of the art in 2012.
Fava C, Rege-Cambrin G, Saglio G. Fava C, et al. Among authors: rege cambrin g. Curr Oncol Rep. 2012 Oct;14(5):379-86. doi: 10.1007/s11912-012-0253-9. Curr Oncol Rep. 2012. PMID: 22821153 Review.
Corticosteroids can reverse severe imatinib-induced hepatotoxicity.
Ferrero D, Pogliani EM, Rege-Cambrin G, Fava C, Mattioli G, Dellacasa C, Campa E, Perfetti P, Fumagalli M, Boccadoro M. Ferrero D, et al. Among authors: rege cambrin g. Haematologica. 2006 Jun;91(6 Suppl):ECR27. Haematologica. 2006. PMID: 16785130 Free article.
Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11-12, 2013.
Breccia M, Alimena G, Baccarani M, Bocchia M, Di Raimondo F, Gambacorti-Passerini C, Gozzini A, Morra E, Pane F, Pregno P, Rege-Cambrin G, Rosti G, Specchia G, Vigneri P, Saglio G. Breccia M, et al. Among authors: rege cambrin g. Crit Rev Oncol Hematol. 2014 Jun;90(3):181-9. doi: 10.1016/j.critrevonc.2013.12.010. Epub 2013 Dec 17. Crit Rev Oncol Hematol. 2014. PMID: 24405858
109 results